These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28454324)

  • 21. Volumetric and morphological analysis of intraductal papillary mucinous neoplasm of the pancreas using computed tomography and magnetic resonance imaging.
    Murayama S; Kimura W; Hirai I; Takasu N; Takeshita A; Moriya T
    Pancreas; 2011 Aug; 40(6):876-82. PubMed ID: 21747312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intraductal papillary mucinous neoplasm.
    Shi C; Hruban RH
    Hum Pathol; 2012 Jan; 43(1):1-16. PubMed ID: 21777948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SLC2A1/GLUT1 expression in mural nodules of intraductal papillary mucinous neoplasm of the pancreas.
    Oda Y; Aishima S; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Miyazaki T; Tanaka M; Oda Y
    Hum Pathol; 2017 Jul; 65():71-78. PubMed ID: 28412205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytopathologic diagnosis of oncocytic type intraductal papillary mucinous neoplasm: Criteria and clinical implications of accurate diagnosis.
    Reid MD; Stallworth CR; Lewis MM; Akkas G; Memis B; Basturk O; Adsay V
    Cancer Cytopathol; 2016 Feb; 124(2):122-34. PubMed ID: 26415076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nuclear expression of STAT5 in intraductal papillary mucinous neoplasms of the pancreas.
    Kataoka TR; Ioka T; Tsukamoto Y; Matsumura M; Ishiguro S; Nishizawa Y
    Int J Surg Pathol; 2007 Jul; 15(3):277-81. PubMed ID: 17652536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carcinoembryonic antigen level in the pancreatic juice is effective in malignancy diagnosis and prediction of future malignant transformation of intraductal papillary mucinous neoplasm of the pancreas.
    Hayakawa H; Fukasawa M; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Kawakami S; Fukasawa Y; Maekawa S; Inoue T; Yamaguchi T; Nakayama Y; Kawaida H; Kono H; Mochizuki K; Kondo T; Ichikawa D; Enomoto N
    J Gastroenterol; 2019 Nov; 54(11):1029-1037. PubMed ID: 31111221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic intraductal papillary mucinous neoplasm--where is the challenge?
    Fritz S; Hackert T; Büchler MW
    Dig Dis; 2015; 33(1):99-105. PubMed ID: 25531503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil to Lymphocyte Ratio is a Predictive Factor of Malignant Potential for Intraductal Papillary Mucinous Neoplasms of the pancreas.
    Ohno R; Kawamoto R; Kanamoto M; Watanabe J; Fujii M; Ohtani H; Harada M; Kumagi T; Kawasaki H
    Biomark Insights; 2019; 14():1177271919851505. PubMed ID: 31210727
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of the DNA damage checkpoint pathway in intraductal papillary mucinous neoplasms of the pancreas.
    Miyasaka Y; Nagai E; Yamaguchi H; Fujii K; Inoue T; Ohuchida K; Yamada T; Mizumoto K; Tanaka M; Tsuneyoshi M
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4371-7. PubMed ID: 17671118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.
    Walter TC; Steffen IG; Stelter LH; Maurer MH; Bahra M; Faber W; Klein F; Bläker H; Hamm B; Denecke T; Grieser C
    Eur Radiol; 2015 May; 25(5):1329-38. PubMed ID: 25433414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular and clinical patterns of local progression in the pancreatic remnant following resection of pancreatic intraductal papillary mucinous neoplasm (IPMN).
    Sereni E; Luchini C; Salvia R; Pea A
    Chin Clin Oncol; 2019 Apr; 8(2):21. PubMed ID: 31070041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal Papillary Mucinous Neoplasm of the Pancreas: Current Perspectives.
    Dumlu EG; Karakoç D; Özdemir A
    Int Surg; 2015 Jun; 100(6):1060-8. PubMed ID: 26414828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraductal papillary-mucinous neoplasms of the pancreas: an analysis of in situ and invasive carcinomas in 28 patients.
    Adsay NV; Conlon KC; Zee SY; Brennan MF; Klimstra DS
    Cancer; 2002 Jan; 94(1):62-77. PubMed ID: 11815961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
    Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
    Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CT and MR imaging features of fistulas from intraductal papillary mucinous neoplasms of the pancreas to adjacent organs: A retrospective study of 423 patients.
    Ravaud S; Laurent V; Jausset F; Cannard L; Mandry D; Oliver A; Claudon M
    Eur J Radiol; 2015 Nov; 84(11):2080-8. PubMed ID: 26321495
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid Growth Rates of Suspected Pancreatic Cyst Branch Duct Intraductal Papillary Mucinous Neoplasms Predict Malignancy.
    Kwong WT; Lawson RD; Hunt G; Fehmi SM; Proudfoot JA; Xu R; Giap A; Tang RS; Gonzalez I; Krinsky ML; Savides TJ
    Dig Dis Sci; 2015 Sep; 60(9):2800-6. PubMed ID: 25924899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraductal papillary mucinous neoplasms of the pancreas: radiological predictors of malignant transformation and the introduction of bile duct dilation to current guidelines.
    Strauss A; Birdsey M; Fritz S; Schwarz-Bundy BD; Bergmann F; Hackert T; Kauczor HU; Grenacher L; Klauss M
    Br J Radiol; 2016; 89(1061):20150853. PubMed ID: 26959611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.